Pfizer CEO Albert Bourla says the company is looking for "superior" results on weight-loss drugs. Speaking with Bloomberg's Katie Greifeld at JPMorgan's annual health-care conference in San Francisco, Bourla also says he is "very satisfied" with Pfizer's current portfolio.

Pfizer CEO Albert Bourla says the company is looking for "superior" results on weight-loss drugs. Speaking with Bloomberg's Katie Greifeld at JPMorgan's annual health-care conference in San Francisco, Bourla also says he is "very satisfied" with Pfizer's current portfolio.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Pfizer CEO Albert Bourla Talks Weight Loss Drugs

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/4b7fe9af-44d1-4dbd-aee8-b3d00150cd28/transcript

Eric Rosengren, former Boston Fed President, says administration actions could weaken confidence in Fed independence and complicate rate cuts. He tells Romaine Bostick on “The Close” that even if short-term rates fall, long-term rates may rise as markets fear persistent inflation.

Eric Rosengren, former Boston Fed President, says administration actions could weaken confidence in Fed independence and complicate rate cuts. He tells Romaine Bostick on &ldquo;The Close&rdquo; that even if short-term rates fall, long-term rates may rise as markets fear persistent inflation.

Eric Rosengren Talks Fed

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9c8d484e-e451-4eda-8225-b3d10170b712/transcript

Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference. 

Novo Nordisk CEO Mike Doustdar talks about launching a pill version of their blockbuster obesity drug Wegovy in the US. He speaks to Katie Greifeld in San Francisco at the annual JPMorgan Healthcare Conference.&nbsp;

Mike Doustdar Talks Strong Demand for Weight Loss Pills

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b653fc15-c4aa-4547-a7b7-b3d1016f9887/transcript

Nouriel Roubini, chairman at Roubini Macro Associates, discusses his bullish stance on the role of AI in driving US GDP and productivity and explains why he is downplaying geopolitical risks to markets.

Nouriel Roubini, chairman at Roubini Macro Associates, discusses his bullish stance on the role of AI in driving US GDP and productivity and explains why he is downplaying geopolitical risks to markets.

Nouriel Roubini Talks Tech Led Boom, Geopolitics

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/35659939-9dd2-43d9-a9ce-b3d10109b01a/transcript

Pfizer CEO Albert Bourla Talks Weight Loss Drugs

Bloomberg Talks

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips